FdaApplication
ANDA 218948
Identifiers
- fda_app_no: ANDA218948
Properties
| Property | Value |
|---|---|
| applicant_name | AUROBINDO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2025-04-15 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE;ORAL |
| ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | EQ 5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE;ORAL |
| ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | EQ 40MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE;ORAL |
3 products